Medical bioreactor market is growing due to rising demand for biopharmaceuticals, advancements in cell culture technologies, ...

Thanks to increased healthcare spending and growing pharma capabilities. The Asia-Pacific is expected to witness the fastest ...

To address this challenge, CTMC has established a patient material bank, enabling early-stage process development with clinically relevant samples. This resource also supports continuous process ...

Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the ...

Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...

Cell therapy is a field rife with innovation, but most of the novel therapies being developed fall into one of two basic categories: autologous cell therapies, which involve removing a patient’s ...

It's another wild twist in the story of Galapagos, a company that has been around for more than 25 years but has yet to get a ...

A recently developed cancer treatment called chimeric antigen receptor T-cell therapy (CAR T-cell therapy, for short) offers hope to people whose diffuse large B-cell lymphoma (DLBCL) has proved ...

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors ...

This approach increases neurite outgrowth by 90%, addressing key limitations in stem cell therapy for neurodegenerative diseases and offering improved precision and efficacy for neural regeneration.